The US company’s two simultaneous trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

Quantum Computing sees a 10% drop post-earnings. I downgraded QUBT stock to a sell due to overvaluation and speculative ...

Incyte declines as data from phase III studies on povorcitinib, for the treatment of hidradenitis suppurativa, fail to meet investor expectations.

Myles Garrett's plan to let his actions do the talking and make sure his teammates chalk his trade request up to the business ...

“…the index is likely completing an irregular expanded flat in EW terms: W>c>b>a. The ideal target is the 61.8% extension … at $19940, which the index is getting close to today … . If the index can ...

The stock market is in correction territory, with risks from protectionism reminiscent of the 1920s, potentially leading to a ...

ESPN writer changes his grade on the Ronnie Stanley signing. Free-agent guards the Ravens could consider. Jeff Zrebiec mocks Texas cornerback to the Ravens.

Senator Deborah O’Neill, who has been a champion of car dealers ever since Holden pulled out of Australia, said the ...

But Robert Dietz, chief economist at the National Association of Home Builders, says policy uncertainty is the industry’s ...

Joey McIntyre has been a staple in the pop music landscape. As the youngest member of New Kids on the Block, he skyrocketed to fame duri ...

Despite emitting more carbon than coal, the government backs Lynemouth’s green credentials—granting its owner £700 million in ...

The FTSE 100 index was down 22.84 points, 0.3%, at 8,683.82. The FTSE 250 was down 30.34 points, 0.2%, at 20,092.03, and the AIM All-Share was up just 0.35 of a point, 0.1%, at 694.97.